Search research articles
Contact Us
Filters
Showing results (21-30 of 183) with videos related to
Page
of 19
Sort By:
Metabolism: Clinical and Experimental
|
August 1, 1994
Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis
G Salen, A K Batta, G S Tint, et al.
Journal of Lipid Research
|
November 1, 1995
Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome
A K Batta, G Salen, G S Tint, et al.
American Journal of Medical Genetics
|
March 10, 2000
Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-G-->C is found in over sixty percent of US propositi
H Yu, G S Tint, G Salen, et al.
The Journal of Clinical Investigation
|
May 1, 1974
A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain
T Setoguchi, G Salen, G S Tint, et al.
American Journal of Medical Genetics
|
December 18, 1998
Atypical case of Smith-Lemli-Opitz syndrome: implications for diagnosis
B Angle, G S Tint, O A Yacoub, et al.
Steroids
|
September 1, 1979
Preparation of [3beta-3H] labeled bile acids and bile alcohols
B Dayal, E Bagan, G S Tint, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
May 1, 1992
Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia
G Salen, G S Tint, S Shefer, et al.
Steroids
|
February 1, 1981
p-Toluenesulfonic acid/methanol: mild reagent for the preparation of bile acid methyl esters
B Dayal, J Speck, E Bagan, et al.
American Journal of Medical Genetics
|
January 31, 1997
Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome
D B Dehart, L Lanoue, G S Tint, et al.
Steroids
|
March 1, 1975
New bile alcohols--synthesis of 5beta-cholestane-3alpha, 7alpha, 25-triol and 5beta-cholestane-3alpha, 7alpha, 25-24 (14C)-triol
B I Cohen, G S Tint, T Kuramoto, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 183) with videos related to
Sort By:
Page
of 19
Metabolism: Clinical and Experimental
|
August 1, 1994
Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis
G Salen, A K Batta, G S Tint, et al.
Journal of Lipid Research
|
November 1, 1995
Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome
A K Batta, G Salen, G S Tint, et al.
American Journal of Medical Genetics
|
March 10, 2000
Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-G-->C is found in over sixty percent of US propositi
H Yu, G S Tint, G Salen, et al.
The Journal of Clinical Investigation
|
May 1, 1974
A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain
T Setoguchi, G Salen, G S Tint, et al.
American Journal of Medical Genetics
|
December 18, 1998
Atypical case of Smith-Lemli-Opitz syndrome: implications for diagnosis
B Angle, G S Tint, O A Yacoub, et al.
Steroids
|
September 1, 1979
Preparation of [3beta-3H] labeled bile acids and bile alcohols
B Dayal, E Bagan, G S Tint, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
May 1, 1992
Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia
G Salen, G S Tint, S Shefer, et al.
Steroids
|
February 1, 1981
p-Toluenesulfonic acid/methanol: mild reagent for the preparation of bile acid methyl esters
B Dayal, J Speck, E Bagan, et al.
American Journal of Medical Genetics
|
January 31, 1997
Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome
D B Dehart, L Lanoue, G S Tint, et al.
Steroids
|
March 1, 1975
New bile alcohols--synthesis of 5beta-cholestane-3alpha, 7alpha, 25-triol and 5beta-cholestane-3alpha, 7alpha, 25-24 (14C)-triol
B I Cohen, G S Tint, T Kuramoto, et al.
Page
of 19